蘑菇AV

For brands, working with influencers was once an experimental addition to their media plans, but growth in influencer marketing spend is now outpacing its digital and social counterparts, per our forecast. While influencer partnerships still account for a significantly smaller part of the media mix, their growth is a sign that the industry is maturing鈥攁nd more legacy advertisers want in.

Social media is crucial for B2B marketing success. In 2024, B2B marketers are embracing influencer marketing and video, integrating AI, and focusing on the importance of authenticity. B2B marketers can gain insights for enhancing brand awareness, optimizing campaigns, and building meaningful connections with target audiences.

Amazon takes on social media 颈苍蹿濒耻别苍肠别谤蝉鈥� product testimonials: If influencers don鈥檛 disclose their relationships with sellers, those merchants could find themselves suspended from the platform.

Social media fuels micro-dosing trend with Ozempic: The trend speaks to the power of social health influencers, but emphasizes responsibility to marketers who need to make sure consumers are getting the most accurate drug information on the channel.

Influencer marketing is becoming a need-to-have for payment brands鈥� marketing teams. While not without risks, it鈥檚 key to building awareness and creating relationships with young consumers.

Dr. Oz could be investigated for violating FTC influencer marketing guidelines: A consumer advocacy group triggered the investigation. We examine the complaints and explore what this scrutiny means for healthcare influencers.

Instagram launches Trial Reels: Creators can test content with nonfollowers before sharing it widely to cater to increasingly data-driven influencers.

Social health influencers can change physicians鈥� prescribing choices: But only if a campaign focuses on certain factors physicians value, like credibility.

News influencers are overwhelmingly male and lean right-wing: Brands looking for creators have to carefully pick apart values to ensure an ideological match.

Many creators are reporting a deal drought, even as marketers are increasing their influencer budgets. That鈥檚 because the dynamics of the influencer-brand deal landscape are evolving.

FDA says Merz Pharma鈥檚 Instagram ad is misleading: The regulator could be ramping up its oversight of drug ads on social media that involve influencers.

In today鈥檚 episode of The Banking & Payments Show podcast we talk about how financial services companies partner with creators on social media to reach younger audiences. In the 鈥楬eadlines鈥� segment we examine the partnerships between banks and influencers by discussing the 蘑菇AV article, 鈥淗ow to make finfluencer partnerships work with a smaller marketing budget.鈥� And in the 鈥楽tory by Numbers鈥� segment, we shift the conversation to how many financial influencers there are on social media and the steps a bank needs to take to find the right finfluencer to partner with. Join the discussion with host, Rob Rubin, content creator and finfluencer, Taylor Mitchell, and analyst, Lauren Ashcraft.